NEW YORK--(BUSINESS WIRE)-- Today, Affinity Solutions, the leading Consumer Purchase Data platform focused on delivering improved business outcomes, and National CineMedia (NCM®), America’s largest ...
Atrasentan demonstrated mean proteinuria reductions of 38.1% proteinuria at six weeks of treatment, 48.3% at 12 weeks of treatment and 54.7% at 24 weeks of treatment There were no meaningful changes ...
REDWOOD CITY, Calif., May 28, 2024 /PRNewswire/ -- Galvanize today announced that it received U.S. Food and Drug Administration 510(k) regulatory clearance for the INUMI Flex endoscopic needle for use ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback